PMDA — authorised 23 January 2020
- Marketing authorisation holder: Japan Tobacco
- Status: approved
PMDA authorised Corectim on 23 January 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 23 January 2020; PMDA has authorised it.
Japan Tobacco holds the Japanese marketing authorisation.